Back to MA Mirae Asset Global Investments Co., Ltd.

VERVVERV
14 quarters

Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in VERVE THERAPEUTICS INC

As of its Q2 2025 13F, Mirae Asset Global Investments held 3,444 shares of VERV (Verve Therapeutics), worth $38,677. Mirae Asset Global Investments' 13F filings listed VERV from Q2 2022 to Q2 2025, 13 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.8M

Total Shares Change

-117,698

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q2
Increased
3,444
+15.9%
$38,6770.0%—
23
2025-Q1
Increased
2,971
+5.3%
$15,5090.0%—
19
2024-Q4
Decreased
2,821
-7.8%
$16,9820.0%—
0
2024-Q3
Increased
3,061
+22.1%
$15,2440.0%—
22
2024-Q2
Decreased
2,507
-98.5%
$11,9330.0%—
0
2024-Q1
Increased
171,795
+52.4%
$2.4M0.0%—
36
2023-Q4
Decreased
112,761
-46.8%
$1.6M0.0%—
0
2023-Q3
Increased
212,104
+8.9%
$2.8M0.0%—
29
2023-Q2
Increased
194,827
+15.3%
$3.7M0.0%—
31
2023-Q1
Increased
168,946
+7.8%
$2.4M0.0%—
28
2022-Q4
Increased
156,781
+14.6%
$3M0.0%—
30
2022-Q3
Increased
136,799
+16.2%
$4.7M0.0%—
31
2022-Q2
New
117,698
-
$1.8M0.0%—
36

Other major holders of VERV: Alphabet Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used